Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 15 | 2023 | 19 | 5.170 |
Why?
|
| Rhinitis | 11 | 2023 | 17 | 3.630 |
Why?
|
| Bacteria | 8 | 2020 | 245 | 2.130 |
Why?
|
| Paranasal Sinuses | 6 | 2020 | 6 | 1.890 |
Why?
|
| RNA, Ribosomal, 16S | 9 | 2023 | 165 | 1.010 |
Why?
|
| Malassezia | 2 | 2020 | 5 | 0.920 |
Why?
|
| Cystic Fibrosis | 2 | 2022 | 19 | 0.890 |
Why?
|
| Chronic Disease | 12 | 2023 | 469 | 0.860 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2020 | 57 | 0.660 |
Why?
|
| Bronchi | 1 | 2018 | 45 | 0.660 |
Why?
|
| Biofilms | 4 | 2020 | 166 | 0.650 |
Why?
|
| Nasal Cavity | 1 | 2017 | 11 | 0.620 |
Why?
|
| Anti-Infective Agents | 2 | 2023 | 62 | 0.610 |
Why?
|
| Pseudomonas Infections | 1 | 2016 | 18 | 0.590 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 455 | 0.530 |
Why?
|
| Nasal Mucosa | 5 | 2023 | 29 | 0.480 |
Why?
|
| Inflammation | 1 | 2018 | 577 | 0.470 |
Why?
|
| Haemophilus influenzae | 1 | 2011 | 5 | 0.420 |
Why?
|
| Methane | 1 | 2011 | 7 | 0.420 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 28 | 0.420 |
Why?
|
| RNA, Bacterial | 3 | 2017 | 29 | 0.400 |
Why?
|
| Virulence | 1 | 2011 | 221 | 0.400 |
Why?
|
| Silver | 1 | 2011 | 53 | 0.390 |
Why?
|
| Nasal Polyps | 3 | 2023 | 3 | 0.390 |
Why?
|
| Fungi | 1 | 2011 | 86 | 0.380 |
Why?
|
| Flagella | 1 | 2009 | 29 | 0.350 |
Why?
|
| Humans | 21 | 2023 | 34853 | 0.320 |
Why?
|
| Computational Biology | 2 | 2021 | 275 | 0.320 |
Why?
|
| Carrier Proteins | 1 | 2009 | 287 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 355 | 0.310 |
Why?
|
| Nanoparticles | 1 | 2011 | 294 | 0.300 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 968 | 0.290 |
Why?
|
| Animals | 9 | 2023 | 14307 | 0.240 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 80 | 0.230 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2023 | 17 | 0.230 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 12 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 41 | 0.200 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2333 | 0.200 |
Why?
|
| Gastrointestinal Tract | 2 | 2019 | 59 | 0.190 |
Why?
|
| Microbial Viability | 2 | 2011 | 35 | 0.190 |
Why?
|
| Clostridium Infections | 1 | 2019 | 5 | 0.180 |
Why?
|
| Dog Diseases | 1 | 2019 | 26 | 0.170 |
Why?
|
| Young Adult | 3 | 2017 | 4012 | 0.170 |
Why?
|
| Nose | 1 | 2018 | 14 | 0.170 |
Why?
|
| Microbial Interactions | 1 | 2018 | 10 | 0.160 |
Why?
|
| Software | 1 | 2019 | 204 | 0.160 |
Why?
|
| Endoscopy | 1 | 2017 | 15 | 0.150 |
Why?
|
| Aged | 3 | 2017 | 6448 | 0.150 |
Why?
|
| Mice | 4 | 2022 | 5668 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2018 | 1353 | 0.150 |
Why?
|
| Arginase | 1 | 2016 | 12 | 0.150 |
Why?
|
| Aspergillus flavus | 1 | 2016 | 2 | 0.140 |
Why?
|
| Aspergillus fumigatus | 1 | 2016 | 10 | 0.140 |
Why?
|
| Middle Aged | 3 | 2017 | 9642 | 0.130 |
Why?
|
| Female | 4 | 2017 | 19873 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2014 | 203 | 0.130 |
Why?
|
| Fosfomycin | 1 | 2014 | 5 | 0.130 |
Why?
|
| Bacterial Infections | 2 | 2011 | 44 | 0.130 |
Why?
|
| Hypertension | 1 | 2021 | 770 | 0.120 |
Why?
|
| Aquaporin 5 | 1 | 2013 | 1 | 0.120 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 40 | 0.120 |
Why?
|
| Phylogeny | 1 | 2017 | 612 | 0.120 |
Why?
|
| RNA | 2 | 2013 | 234 | 0.120 |
Why?
|
| Adult | 3 | 2017 | 11034 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1300 | 0.110 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 25 | 0.110 |
Why?
|
| Probiotics | 1 | 2013 | 25 | 0.110 |
Why?
|
| Cytokines | 1 | 2016 | 569 | 0.110 |
Why?
|
| Interleukin-13 | 2 | 2023 | 18 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2023 | 57 | 0.110 |
Why?
|
| Cilia | 1 | 2012 | 23 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1530 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2011 | 96 | 0.100 |
Why?
|
| Mycoses | 1 | 2011 | 29 | 0.100 |
Why?
|
| Genes, Bacterial | 1 | 2011 | 88 | 0.100 |
Why?
|
| Biopsy | 1 | 2011 | 151 | 0.100 |
Why?
|
| DNA Primers | 1 | 2011 | 269 | 0.100 |
Why?
|
| Time Factors | 2 | 2014 | 1681 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 45 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2011 | 171 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 520 | 0.090 |
Why?
|
| Male | 3 | 2017 | 18870 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2013 | 486 | 0.090 |
Why?
|
| Lactoferrin | 1 | 2009 | 4 | 0.090 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 66 | 0.090 |
Why?
|
| Leukocytes | 1 | 2009 | 68 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2009 | 156 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 639 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 874 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 325 | 0.080 |
Why?
|
| Smoking | 1 | 2011 | 903 | 0.060 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 4 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2023 | 73 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2023 | 54 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2023 | 115 | 0.060 |
Why?
|
| Respiratory System | 1 | 2022 | 21 | 0.050 |
Why?
|
| Body Weight | 1 | 2023 | 404 | 0.050 |
Why?
|
| Feedback | 1 | 2021 | 46 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2020 | 8 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 48 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 24 | 0.040 |
Why?
|
| Enterotoxins | 1 | 2019 | 32 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2019 | 44 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 138 | 0.040 |
Why?
|
| Phospholipids | 1 | 2019 | 68 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 288 | 0.040 |
Why?
|
| Rats | 1 | 2023 | 3261 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 818 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 366 | 0.030 |
Why?
|
| Obesity | 1 | 2023 | 965 | 0.030 |
Why?
|
| Kanamycin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Hemiterpenes | 1 | 2014 | 7 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 13 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cadherins | 1 | 2013 | 82 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 181 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 145 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 298 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2012 | 5 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2013 | 834 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 859 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2012 | 1442 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 5035 | 0.020 |
Why?
|